Guidance for Industry - Priority Review of Drug Submissions

This guidance aims to articulate Health Canada's expectations and generate a level of consistency regarding the interpretation of the Priority Review of Drug Submissions policy and the filing of a Priority Review request. Additional clarification of the process by which the Priority Review request is assessed is provided.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-07-07

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data